KAST Stock Overview
Kasten, Inc., doing business as DAKOTA Life Sciences, operates as a biopharmaceutical company that focuses on the acquisition, development, and commercialization of pharmaceuticals designed to prevent and treat serious conditions arising in hospital and community settings. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Kasten, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.006 |
| 52 Week High | US$0.047 |
| 52 Week Low | US$0.0025 |
| Beta | 0 |
| 11 Month Change | -11.50% |
| 3 Month Change | 0% |
| 1 Year Change | -85.82% |
| 33 Year Change | -80.00% |
| 5 Year Change | 233.33% |
| Change since IPO | -99.52% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| KAST | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 0% | 2.4% | 0.5% |
| 1Y | -85.8% | 15.6% | 30.7% |
Return vs Industry: KAST underperformed the US Biotechs industry which returned 15.6% over the past year.
Return vs Market: KAST underperformed the US Market which returned 30.7% over the past year.
Price Volatility
| KAST volatility | |
|---|---|
| KAST Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 9.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: KAST's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine KAST's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | n/a | n/a | n/a |
Kasten, Inc., doing business as DAKOTA Life Sciences, operates as a biopharmaceutical company that focuses on the acquisition, development, and commercialization of pharmaceuticals designed to prevent and treat serious conditions arising in hospital and community settings. It principally focuses on delivering solutions to those people who are affected by antimicrobial resistance and who need pharmaceutical products at affordable prices. The company was incorporated in 1986 and is based in Yichun, China.
Kasten, Inc. Fundamentals Summary
| KAST fundamental statistics | |
|---|---|
| Market cap | US$246.85k |
| Earnings (TTM) | US$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs KAST overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KAST income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$0 |
| Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did KAST perform over the long term?
See historical performance and comparison